Showing 104,961 - 104,980 results of 154,524 for search '(( 10 ((we decrease) OR (nn decrease)) ) OR ( 5 ((mean decrease) OR (a decrease)) ))', query time: 1.95s Refine Results
  1. 104961
  2. 104962
  3. 104963
  4. 104964
  5. 104965

    DataSheet_1_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.docx by Hongyan Cheng (445898)

    Published 2021
    “…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10<sup>9</sup> cells and a dose-climbing strategy. …”
  6. 104966

    Image_1_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

    Published 2021
    “…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10<sup>9</sup> cells and a dose-climbing strategy. …”
  7. 104967

    Image_3_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

    Published 2021
    “…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10<sup>9</sup> cells and a dose-climbing strategy. …”
  8. 104968

    Image_4_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

    Published 2021
    “…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10<sup>9</sup> cells and a dose-climbing strategy. …”
  9. 104969

    Image_2_Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.tif by Hongyan Cheng (445898)

    Published 2021
    “…We found that 6B11-OCIK treatment was safe and well tolerated after five cycles of intravenous infusion with an initial dose of 1–2×10<sup>9</sup> cells and a dose-climbing strategy. …”
  10. 104970

    Scotopic b-wave characteristic in WT and <i>Fmr1</i> KO mice. by Rafaëlle Rossignol (621196)

    Published 2014
    “…Data are presented as Mean ± SEM. Student’s t test, *p</p>…”
  11. 104971

    Change in skull and brain conformation in Griffon Bruxellois with CM and syringomyelia. by Susan P. Knowler (522309)

    Published 2014
    “…Angles 2 and 5 (yellow) are decreased as a consequence of the cranial base shortening and increased proximity of the atlas to the occiput. …”
  12. 104972

    Bay-11-7082 inhibits NF-κB binding to DNA in breast cancer cells. by Shannon M. Smith (115335)

    Published 2014
    “…<p>Breast cancer cells, MDA-MB-231 (<b>A–C</b>) and SUM159 (<b>D–F</b>), were treated with either a DMSO control or Bay-11-7082 at different concentrations (0.625 µM - 5.0 µM) for 24, 48 or 72 hrs. …”
  13. 104973

    SMF-3::GFP is down-regulated upon Mn exposure. by Catherine Au (242983)

    Published 2013
    “…C, SMF-3::GFP signal is strongly decreased at 5 hours post-treatment. After a day of recovery, SMF-3::GFP expression returns to control levels and SMF-3::GFP relocates to the apical plasma membrane (D). …”
  14. 104974

    Quantification of GFAP/PCNA-positive cells in APC in young and culture aged APC upon hypoxia/Glu/EPO-exposure. by Ali Lourhmati (374594)

    Published 2013
    “…Hypoxia decreased the proliferation of APC (cf- N+Glu vs. H+Gu); (<b>B</b>) Quantification of GFAP/PCNA+ cells on DIV21 shows no changes in PCNA+ astrocytes exposed to EPO under normoxia (white bars), while a significant increase (**p<0.01) is detected in EPO-treated APC (H+Glu+5U E) under hypoxia (grey bars), as compared with the hypoxic control (H+Glu). …”
  15. 104975

    Table_3_Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.xlsx by Xin Huang (11077)

    Published 2022
    “…Its transcriptional level significantly increased in T2D mice, but surprisingly decreased in T2D patients with SARS-CoV-2 infection. …”
  16. 104976

    Table_4_Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.xlsx by Xin Huang (11077)

    Published 2022
    “…Its transcriptional level significantly increased in T2D mice, but surprisingly decreased in T2D patients with SARS-CoV-2 infection. …”
  17. 104977

    Table_1_Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.docx by Xin Huang (11077)

    Published 2022
    “…Its transcriptional level significantly increased in T2D mice, but surprisingly decreased in T2D patients with SARS-CoV-2 infection. …”
  18. 104978

    Image_1_Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.tif by Xin Huang (11077)

    Published 2022
    “…Its transcriptional level significantly increased in T2D mice, but surprisingly decreased in T2D patients with SARS-CoV-2 infection. …”
  19. 104979

    Image_2_Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.tif by Xin Huang (11077)

    Published 2022
    “…Its transcriptional level significantly increased in T2D mice, but surprisingly decreased in T2D patients with SARS-CoV-2 infection. …”
  20. 104980

    Table_2_Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.xlsx by Xin Huang (11077)

    Published 2022
    “…Its transcriptional level significantly increased in T2D mice, but surprisingly decreased in T2D patients with SARS-CoV-2 infection. …”